These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22029676)

  • 1. Trientine and renin-angiotensin system blockade ameliorate progression of glomerular morphology in hypertensive experimental diabetic nephropathy.
    Moya-Olano L; Milne HM; Robinson JM; Hill JV; Frampton CM; Abbott HF; Turner R; Kettle AJ; Endre ZH
    Pathol Int; 2011 Nov; 61(11):652-61. PubMed ID: 22029676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy.
    Yao Y; Fomison-Nurse IC; Harrison JC; Walker RJ; Davis G; Sammut IA
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F251-62. PubMed ID: 24899056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
    Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats.
    Nicholas SB; Mauer M; Basgen JM; Aguiniga E; Chon Y
    Am J Nephrol; 2004; 24(5):549-56. PubMed ID: 15539791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.
    Mifsud SA; Allen TJ; Bertram JF; Hulthen UL; Kelly DJ; Cooper ME; Wilkinson-Berka JL; Gilbert RE
    Diabetologia; 2001 Jul; 44(7):878-82. PubMed ID: 11508273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
    Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
    Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ramipril alone compared to ramipril with eplerenone on diabetic nephropathy in streptozocin-induced diabetic rats.
    Mavrakanas TA; Cheva A; Kallaras K; Karkavelas G; Mironidou-Tzouveleki M
    Pharmacology; 2010; 86(2):85-91. PubMed ID: 20689340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes.
    Gong D; Lu J; Chen X; Reddy S; Crossman DJ; Glyn-Jones S; Choong YS; Kennedy J; Barry B; Zhang S; Chan YK; Ruggiero K; Phillips AR; Cooper GJ
    Diabetologia; 2008 Sep; 51(9):1741-51. PubMed ID: 18636238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
    Hill JV; Findon G; Appelhoff RJ; Endre ZH
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
    Kato S; Luyckx VA; Ots M; Lee KW; Ziai F; Troy JL; Brenner BM; MacKenzie HS
    Kidney Int; 1999 Sep; 56(3):1037-48. PubMed ID: 10469372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats.
    Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R
    Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential contribution of diabetes and the Ren2 gene to glomerular pathology in diabetic (mREN-2)27 rats.
    Appelhoff RJ; Hill JV; Findon G; Frampton CM; Perry E; Ponnamperuma D; Endre ZH
    Lab Invest; 2010 Aug; 90(8):1225-35. PubMed ID: 20458279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.
    Deb DK; Sun T; Wong KE; Zhang Z; Ning G; Zhang Y; Kong J; Shi H; Chang A; Li YC
    Kidney Int; 2010 Jun; 77(11):1000-9. PubMed ID: 20182412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy.
    de Alencar Franco Costa D; Todiras M; Campos LA; Cipolla-Neto J; Bader M; Baltatu OC
    Acta Physiol (Oxf); 2015 Mar; 213(3):740-6. PubMed ID: 25529203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
    Kamal F; Yanakieva-Georgieva N; Piao H; Morioka T; Oite T
    Nephron Exp Nephrol; 2010; 115(3):e69-79. PubMed ID: 20424485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.